4/27/22 16:34 | 4/25/22 | FUSN | Fusion Pharmaceuticals Inc. | Z4 | Health | BioPrd | Biological Products, (No Diag | Valliant John | MA | DO | CEO | S.m | -53 | 6.04 | 0 | -9 | -3 | 318 | D | | | | | | | | | | | | | | |
4/22/22 20:04 | 4/20/22 | FUSN | Fusion Pharmaceuticals Inc. | Z4 | Health | BioPrd | Biological Products, (No Diag | Valliant John | MA | DO | CEO | S.m | -8 | 6.01 | 0 | -1 | 0 | 327 | D | | | | | | | | | | | | | | |
4/13/22 18:10 | 4/11/22 | FUSN | Fusion Pharmaceuticals Inc. | Z4 | Health | BioPrd | Biological Products, (No Diag | Valliant John | MA | DO | CEO | S.m | -226 | 6.87 | 0 | -33 | -9 | 328 | D | | | | | | | | | | | | | | |
4/8/22 16:21 | 4/6/22 | FUSN | Fusion Pharmaceuticals Inc. | Z4 | Health | BioPrd | Biological Products, (No Diag | Valliant John | MA | DO | CEO | S.m | -16 | 7.55 | 0 | -2 | -1 | 361 | D | | | | | | | | | | | | | | |
4/5/22 17:01 | 4/1/22 | FUSN | Fusion Pharmaceuticals Inc. | Z4 | Health | BioPrd | Biological Products, (No Diag | Valliant John | MA | DO | CEO | S.m | -29 | 7.72 | 0 | -4 | -1 | 363 | D | | | | | | | | | | | | | | |
4/1/22 17:36 | 3/30/22 | FUSN | Fusion Pharmaceuticals Inc. | Z4 | Health | BioPrd | Biological Products, (No Diag | Valliant John | MA | DO | CEO | S | -2 | 7.52 | 0 | 0 | 0 | 367 | D | | | | | | | | | | | | | | |
3/29/22 16:29 | 3/25/22 | FUSN | Fusion Pharmaceuticals Inc. | Z4 | Health | BioPrd | Biological Products, (No Diag | Valliant John | MA | DO | CEO | S.m | -78 | 7.54 | 0 | -10 | -3 | 367 | D | | | | | | | | | | | | | | |
3/24/22 17:32 | 3/22/22 | FUSN | Fusion Pharmaceuticals Inc. | Z4 | Health | BioPrd | Biological Products, (No Diag | Valliant John | MA | DO | CEO | S.m | -36 | 7.52 | 0 | -5 | -1 | 378 | D | | | | | | | | | | | | | | |
3/21/22 17:47 | 3/17/22 | FUSN | Fusion Pharmaceuticals Inc. | Z4 | Health | BioPrd | Biological Products, (No Diag | Valliant John | MA | DO | CEO | S.m | -27 | 7.53 | 0 | -4 | -1 | 382 | D | | | | | | | | | | | | | | |
3/16/22 16:29 | 3/14/22 | FUSN | Fusion Pharmaceuticals Inc. | Z4 | Health | BioPrd | Biological Products, (No Diag | Valliant John | MA | DO | CEO | S.m | -10 | 6.97 | 0 | -2 | 0 | 386 | D | | | | | | | | | | | | | | |
3/14/22 16:18 | 3/9/22 | FUSN | Fusion Pharmaceuticals Inc. | Z4 | Health | BioPrd | Biological Products, (No Diag | Valliant John | MA | DO | CEO | S.m | -20 | 7.03 | 0 | -3 | -1 | 387 | D | | | | | | | | | | | | | | |
3/8/22 16:59 | 3/4/22 | FUSN | Fusion Pharmaceuticals Inc. | Z4 | Health | BioPrd | Biological Products, (No Diag | Valliant John | MA | DO | CEO | S.m | -104 | 7.17 | 0 | -15 | -4 | 390 | D | | | | | | | | | | | | | | |
3/3/22 16:53 | 3/1/22 | FUSN | Fusion Pharmaceuticals Inc. | Z4 | Health | BioPrd | Biological Products, (No Diag | Valliant John | MA | DO | CEO | S.m | -205 | 7.44 | 0 | -28 | -6 | 405 | D | | | | | | | | | | | | | | |
2/28/22 19:13 | 2/24/22 | FUSN | Fusion Pharmaceuticals Inc. | Z4 | Health | BioPrd | Biological Products, (No Diag | Valliant John | MA | DO | CEO | S.m | -103 | 7.50 | 0 | -14 | -3 | 432 | D | | | | | | | | | | | | | | |